Neville Rodie & Shaw’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-93,069
| Closed | -$9.24M | – | 250 |
|
|
2019
Q3 | $9.24M | Sell |
93,069
-670
| -0.7% | -$63.7K | 0.98% | 31 |
|
|
2019
Q2 | $8.66M | Sell |
93,739
-7,865
| -8% | -$747K | 0.92% | 32 |
|
|
2019
Q1 | $9.59M | Sell |
101,604
-3,707
| -4% | -$324K | 1.02% | 29 |
|
|
2018
Q4 | $6.75M | Sell |
105,311
-12,319
| -10% | -$909K | 0.82% | 39 |
|
|
2018
Q3 | $10.5M | Buy |
117,630
+2,050
| +2% | +$181K | 1.04% | 29 |
|
|
2018
Q2 | $9.18M | Sell |
115,580
-9,691
| -8% | -$805K | 0.97% | 33 |
|
|
2018
Q1 | $11.2M | Buy |
125,271
+33,791
| +37% | +$3.24M | 1.23% | 23 |
|
|
2017
Q4 | $9.55M | Buy |
91,480
+21,012
| +30% | +$2.37M | 1.01% | 32 |
|
|
2017
Q3 | $10.3M | Buy |
70,468
+3,150
| +5% | +$429K | 1.15% | 26 |
|
|
2017
Q2 | $8.74M | Buy |
67,318
+3,015
| +5% | +$369K | 1% | 33 |
|
|
2017
Q1 | $8M | Sell |
64,303
-6,798
| -10% | -$814K | 0.92% | 33 |
|
|
2016
Q4 | $8.23M | Sell |
71,101
-405
| -0.6% | -$45.1K | 0.97% | 31 |
|
|
2016
Q3 | $7.47M | Sell |
71,506
-14,429
| -17% | -$1.56M | 0.88% | 33 |
|
|
2016
Q2 | $8.48M | Sell |
85,935
-1,846
| -2% | -$191K | 1.02% | 29 |
|
|
2016
Q1 | $8.79M | Sell |
87,781
-1,450
| -2% | -$149K | 1.07% | 27 |
|
|
2015
Q4 | $10.7M | Sell |
89,231
-4,265
| -5% | -$493K | 1.28% | 19 |
|
|
2015
Q3 | $10.1M | Buy |
93,496
+2,940
| +3% | +$365K | 1.24% | 21 |
|
|
2015
Q2 | $10.5M | Buy |
90,556
+7,994
| +10% | +$914K | 1.15% | 24 |
|
|
2015
Q1 | $9.52M | Buy |
82,562
+1,680
| +2% | +$201K | 0.99% | 28 |
|
|
2014
Q4 | $9.05M | Buy |
80,882
+400
| +0.5% | +$42.2K | 0.92% | 31 |
|
|
2014
Q3 | $7.63M | Sell |
80,482
-850
| -1% | -$76.7K | 0.75% | 40 |
|
|
2014
Q2 | $6.99M | Sell |
81,332
-1,200
| -1% | -$91.3K | 0.7% | 41 |
|
|
2014
Q1 | $5.76M | Sell |
82,532
-250
| -0.3% | -$19.8K | 0.62% | 47 |
|
|
2013
Q4 | $6.99M | Sell |
82,782
-7,900
| -9% | -$625K | 0.76% | 38 |
|
|
2013
Q3 | $6.99M | Buy |
90,682
+20,600
| +29% | +$1.44M | 0.81% | 35 |
|
|
2013
Q2 | $4.1M | Buy |
+70,082
| New | +$4.22M | 0.5% | 57 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Neville Rodie & Shaw's CELG Position: Q4 2019 in Review
Neville Rodie & Shaw sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 93,069 shares — an estimated $9.24M sold.
Neville Rodie & Shaw first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $11.2M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Neville Rodie & Shaw reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Neville Rodie & Shaw sold 93,069 Celgene Corp shares in Q4 2019, an estimated $9.24M.
- Neville Rodie & Shaw first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Neville Rodie & Shaw's Celgene Corp position peaked at $11.2M in Q1 2018.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Neville Rodie & Shaw's 13F filing for Q4 2019, filed 8 Jan 2020.